2009
DOI: 10.1016/j.bbrc.2008.11.114
|View full text |Cite
|
Sign up to set email alerts
|

Characterizing components of the Saw Palmetto Berry Extract (SPBE) on prostate cancer cell growth and traction

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
24
0
1

Year Published

2010
2010
2023
2023

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 39 publications
(25 citation statements)
references
References 19 publications
0
24
0
1
Order By: Relevance
“…p53 increased after treatment with this extract, whereas p27 and p21 decreased. This report justifies the administration of the entire phytocomplex to ensure a proper pharmacological efficacy not limiting the interest only to free fatty acids [36];…”
Section: Discussionmentioning
confidence: 93%
“…p53 increased after treatment with this extract, whereas p27 and p21 decreased. This report justifies the administration of the entire phytocomplex to ensure a proper pharmacological efficacy not limiting the interest only to free fatty acids [36];…”
Section: Discussionmentioning
confidence: 93%
“…7,15,28 As shown in Figure 3, E-Syt1 bound specifically to biotinylated β-sitosterol at 600 nM, just as in macrophage lysates. In contrast, 17β-HSD4 bound more strongly to biotinylated cholesterol than biotinylated β-sitosterol in both prostate cancer cell lines (Figure 3), which is opposite to what we observed in macrophage lysates.…”
mentioning
confidence: 69%
“…5,17 In support of this hypothesis, β-sitosterol exhibits growth inhibitory and cytotoxic effects against a range of cancer cell lines. 7,1820 However, the precise molecular mechanisms underlying its health promoting effects remain largely uncharacterized. To understand the molecular mechanism(s) by which β-sitosterol exerts its many beneficial health effects, we performed affinity chromatography using biotinylated β-sitosterol to identify its protein targets.…”
mentioning
confidence: 99%
“…Stigmasterol (4b) decreased tumor volume and cell viability, increasing the life span of Ehrlich ascites carcinoma (EAC)-bearing mice (Ghosh, 2011). It was reported that 4a and 4b exhibited anti-proliferative activities against human prostate cancer cells (DU-145) by increasing p53 protein expression and inhibiting carcinoma development by decreasing p21 and p27 protein expression (Scholtysek et al, 2009). Other studies reported that 4b showed cytostatic activity against HEp-2 and McCoy cells (Gómez et al, 2001), significantly inhibited tumor promotion in mouse skin two-stage carcinogenesis experiments (Kasahara et al, 1994), and demonstrated antimutagenic (Lim et al, 2005), and anti-oxidant (Panda et al, 2009) properties.…”
Section: Resultsmentioning
confidence: 99%